Clinical Trials Sponsored by Geropharm

Total 46 results

Geropharm

Completed

A Study to Compare Pharmacokinetics and Pharmacodynamics of RinGlar® to Lantus® in Type 1 Diabetes Mellitus Patients

Clamp Study

Russian Federation
Geropharm

Completed

Efficacy and Safety of Insulin RinGlar® Compared to Lantus® SoloStar® in Type 1 Diabetes Mellitus Patients

Diabetes Mellitus | Diabetes Mellitus, Type 1

Russian Federation
Geropharm

Completed

A Study to Compare Pharmacokinetics and Pharmacodynamics of Insulin Lispro to Humalog® in Healthy Subjects

Clamp Study

Russian Federation
Geropharm

Completed

Bioequivalence Study of Metformin 750 mg Tablets XR Versus Glucophage® Long 750 mg Tablets XR In Normal Healthy Subjects Under Fasting and Fed Conditions

Bioequivalence

Russian Federation
Geropharm

Completed

Comparative Study of the Pharmacokinetics of Rinsulin® Mix 30/70, Suspension for Subcutaneous Administration, 100 IU / ml (OJSC GEROPHARM-Bio, Russia) and Humulin® M3, Suspension for Subcutaneous Administration, 100 IU / ml (Lilly France, France) Using the Euglycemic Hyperinsulinemic Clamp Method

Bioequivalence

Russian Federation
Geropharm

Completed

Bioequivalence Study of GP30101 800 mg (GEROPHARM) Versus PREZISTA® 800 mg ("Jonson&Jonson", Russia)

Bioequivalence

Russian Federation
Geropharm

Completed

A Study to Compare Pharmacokinetics and Pharmacodynamics of Insulin Aspart to NovoRapid® Penfill® in Healthy Subjects

Clamp Study

Russian Federation
Geropharm

Completed

Efficacy and Safety of Insulin Lispro Biphasic 25 Compared to Humalog® Mix 25 in Type 2 Diabetes Mellitus Patients

Diabetes Mellitus, Type 2 | Diabetes Mellitus

Russian Federation
Geropharm

Completed

A Study to Compare Pharmacokinetics and Pharmacodynamics of Insulin Lispro Mix 25 to Humalog® Mix 25 in Healthy Subjects

Clamp Study

Russian Federation
Geropharm

Completed

Bioequivalence Study of Metformin 1000 mg Tablets Immediate Release (IR) Versus Glucophage® 1000 mg Tablets IR In Healthy Subjects

Bioequivalence

Russian Federation
Geropharm

Recruiting

Double-blind, Randomized Comparative Cross-sectional Study of Pharmacodynamics and Pharmacokinetics of Drugs GP40141

Pharmacokinetics | Pharmacodynamics | Bioequivalence

Russian Federation
Geropharm

Completed

Comparative Study of Rinsulin R (GEROPHARM) and Humulin Regular (Eli Lilly) Euglycemic Hyperinsulinemic Clamp Method

Bioequivalence | Therapeutic Equivalency

Russian Federation
Geropharm

Completed

Pharmacokinetics, Safety and Efficacy Study of GP30341 (GEROPHARM, Russia) in Healthy Volunteers and Outpatients With COVID-19

Pharmacokinetics | Efficacy | Safety Issues

Russian Federation
Geropharm

Completed

Comparative Study of Rinsulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (GEROPHARM LLC, Russia) and Humulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (Lilly France, France) Using the Euglycemic Hyperinsulinemic Clamp Method

Pharmacokinetics | Bioequivalence

Russian Federation
Geropharm

Completed

Efficacy and Safety of GP40071 Compared to NovoRapid® Penfill® in Type 1 Diabetes Mellitus Patients

Diabetes | Diabetes Mellitus, Type 1

Russian Federation
Geropharm

Unknown

Efficacy and Safety of GP40081 Сompared to NovoMix® 30 FlexPen® in Type 2 Diabetes Mellitus Patients

Diabetes Mellitus, Type 2 | Diabetes Mellitus

Russian Federation
Geropharm

Completed

A Study to Compare Pharmacokinetics and Pharmacodynamics of GP-40081 to NovoMix® 30 Penfill® in Healthy Subjects

Clamp Study

Russian Federation
Geropharm

Completed

Bioequivalence Study of Bosentan 125 mg Tablets Immediate Release (IR) Versus Tracleer® 125 mg Tablets IR In Healthy Subjects

Bioequivalence

Russian Federation
Geropharm

Completed

Efficacy and Safety of Insulin Rinsulin® NPH Compared to Humulin® NPH in Type 2 Diabetes Mellitus Patients

Diabetes Mellitus, Type 2

Russian Federation
Geropharm

Completed

Fasting Bioequivalence Study of Memantinol 20 mg Tablets Versus Akatinol Memantine® 20 mg Tablets In Normal Healthy Subjects

Bioequivalence, AUC, Cmax, Pharmacokinetics

Russian Federation
PeriPharm

Completed

The Impact of Migraine on Canadians' Productivity: A Real-World Pharmacy-Based Study

Migraine

Canada
Neuropharm

Completed

Open Label Study Investigating Safety and Efficacy of NPL2009 50 mg - 150 mg on Prepulse Inhibition Tests and Continuous Performance Tasks, Adults With Fragile X Syndrome

Fragile X Syndrome

United States
Neuropharm

Terminated

Study of NPL-2003 in Adolescents With Obsessive Compulsive Disorder (OCD)

Obsessive Compulsive Disorder

United States
PeriPharm
Pfizer

Completed

Real-World Outcome Research Study on Quality of Life, Work Productivity and Health Care Resource Utilization in Metastatic Breast Cancer

Metastatic Breast Cancer

Canada
Neuropharm
Autism Speaks

Terminated

Extended Management and Measurement of Autism (EMMA)

Autistic Disorder

United States
Neuropharm
Autism Speaks

Completed

Study of Fluoxetine in Autism (SOFIA)

Autistic Disorder

United States
PeriPharm
Idorsia Pharmaceuticals Ltd.

Not yet recruiting

Real-World Observational Study on Patient-Reported Outcomes in the Treatment of Insomnia With Daridorexant in Canada

Insomnia

Canada
Neopharm Bulgaria Ltd.

Recruiting

Treatment of Adults With Acute Bronchitis in the Primary Healthcare Setting (AАBA)

Acute Bronchitis

Bulgaria
Neopharm Bulgaria Ltd.

Completed

Efficacy and Safety of Sinquanon for Prevention of Antibiotic-associated Diarrhea in Adults (SPAADA)

Antibiotic-associated Diarrhea

Bulgaria
Universidad de Valparaiso
Recalcine (GynoPharm)

Completed

Efficacy of Darifenacin and Physiotherapy for the Treatment of Overactive Bladder in Women

Overactive Bladder

Chile
PeriPharm
Personalized Medicine Partnership for Cancer

Completed

Study to Evaluate Real-world Pharmacoeconomics of Panitumumab in Metastatic Colorectal Cancer Patients

Colorectal Cancer Metastatic

Canada
EnhancedBio USA Inc.
Zenopharm

Recruiting

ER+/HER2- Locally Advanced or Metastatic Breast Cancer (ENZENO Study) (ENZENO)

Metastatic Breast Cancer | Locally Advanced Breast Cancer | HER2-Negative | Estrogen Receptor-Positive

United States, Korea, Republic of
Mylan Pharmaceuticals Inc
Genpharm ULC

Completed

Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fasting State

Healthy

Canada
PeriPharm
Personalized Medicine Partnership for Cancer

Completed

Study to Evaluate Real-world Pharmacoeconomics and Resistance Mechanisms of Panitumumab in Metastatic Colorectal Cancer Patients

Colorectal Cancer Metastatic

Canada
Mylan Pharmaceuticals Inc
Genpharm ULC

Completed

Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fed State

Healthy

Canada
Mylan Pharmaceuticals Inc
Genpharm ULC

Completed

Fed, Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Subjects

Therapeutic Equivalency

Canada
Mylan Pharmaceuticals Inc
Genpharm ULC

Completed

Fasting Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Normal Healthy Subjects

Therapeutic Equivalency

Canada
Mylan Pharmaceuticals Inc
Genpharm ULC

Completed

Comparative Bioavailability Study of Baclofen 20 mg Tablets in Healthy Male Volunteers / Fasting State

Healthy

Canada
Joseph Pergolizzi, MD
LeraPharm Inc.

Terminated

A Study on the Effects of Soulera Herbal Blend Intake on Chronic Stress in Healthy Adults

Chronic Stress

United States
Mylan Pharmaceuticals Inc
Genpharm ULC

Completed

Comparative Bioavailability Study of Clarithromycin 250 mg Tablets

Healthy

Canada
PeriPharm
Imprimis Pharmaceuticals, Inc.; Advance Dosage Forms, Inc.

Terminated

Economic Impact of Dropless Therapy Versus Usual Care for Cataract Surgery: A Real-World Study.

Cataract Surgery

Canada
Clinical Institute of the Brain, Russia
Ever Neuro Pharma GmbH; Nycomed; Veropharm

Completed

Navigation Brain Stimulation for Evaluation of the Neuroprotective Drug Efficiency in Patients After Ischemic Stroke. (3C)

Stroke

Russian Federation
PeriPharm
Jewish General Hospital; Personalized Medicine Partnership for Cancer

Terminated

Study to Evaluate Real-world Pharmacoeconomics of Crizotinib in NSCLC Patients

Non-small Cell Lung Cancer Metastatic

Canada
Bayer
Biogen Netherlands B.V; Novartis Europharm Limited; Merck Europe B.V.

Not yet recruiting

An Observational Study to Learn About the Interferon-beta Exposure of Pregnant Women During the Second and Third Trimester in Finland and Sweden (INFORM)

Multiple Sclerosis (MS)

Sweden, Finland
Pontificia Universidad Catolica de Chile
University of Chile; Laboratorio Gynopharm - CFR

Unknown

A Randomized Trial of Docosahexaenoic Acid Supplementation During Pregnancy to Prevent Deep Placentation Disorders

Premature Birth | Fetal Growth Retardation | Preeclampsia | Stillbirth

Chile
Jewish General Hospital
Pfizer; PeriPharm; Quebec Clinical Research Organization in Cancer; Personalized...

Unknown

Study to Evaluate Resistance Mechanisms and Real-world Pharmacoeconomics of Crizotinib in NSCLC Patients

Non-small Cell Lung Cancer Metastatic

Canada

3

Subscribe